Trial intelligence / Profile preview

Effect of single-dose piroxicam on ovulation after LH surge in healthy women

2010-021195-28Phase 2Completed

Sponsor
Bayer
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of piroxicam in emergency contraception (EC) (4 arms), sponsored by Bayer. Primary endpoint: Proportion of subjects with delayed or inhibited ovulation. Started Jan 2011; status: completed.

02

Drugs

piroxicam
03

Conditions

emergency contraception (EC)

Beyond the preview

Go deeper on 2010-021195-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-021195-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call